DISEASES OF WHITE BLOOD CELLS DISEASES OF WHITE BLOOD CELLS Premed 3 Premed 3 Dr Roopa Dr Roopa.

Slides:



Advertisements
Similar presentations
TA OGUNLESI (FWACP)1 CHILDHOOD LEUKAEMIA. TA OGUNLESI (FWACP)2 LEUKAEMIA Heterogenous group of malignant disorders Characterised by uncontrolled clonal.
Advertisements

Wednesday, February 15th Seth Wander
Chapter 11 Disorders of White Blood Cells and Lymphoid Tissues
HAEMATOLOGY MODULE: LYMPHOMA Adult Medical-Surgical Nursing.
Acute leukemia Mohammed Al-matrafi.
Introduction To Haematological Malignancies
1 Leukemia. 2 Leukemia A group of malignant disorders affecting the blood and blood-forming tissues of A group of malignant disorders affecting the blood.
LEUKEMIA.
Chronic leukaemias Chronic myelogenous leukaemia Chronic myelogenous leukaemia Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia.
LEUKEMIA—HEMATOLOGY {S1}
Leukemia and Lymphoma Dental Views By Fatin Al – Sayes MD, Msc,FRcpath Associate Professor Consultant Hematology Leukemia and Lymphoma Dental Views By.
WHO CLASSIFICATION OF MYELOID NEOPLASMS 2000  Chronic myeloproliferative disorders (CMPD)  Myelodysplastic / myeloproliferative diseases (MDS/MPD) 
LYMPHOMA.
Chronic Lymphocytic Leukemia (CLL) DEFINITION CLL is a neoplastic disease characterized by proliferation and accumulation (blood, marrow and lymphoid.
Chapter 17 Chronic Leukemias.
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
Chronic leukemias. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
Lymphoma DR: Gehan Mohamed.
Chapter 25: Acute Lymphoblastic Leukemia. Causes a wide spectrum of syndromes – From involvement of bone marrow and peripheral blood(leukemias) to those.
Pluripotent hematopoietic stem cells are common ancestral cells for all blood and immune cells.
Lymphoma. ALLMMCLLLymphomas Hematopoietic stem cell Neutrophils Eosinophils Basophils Monocytes Platelets Red cells Myeloid progenitor Myeloproliferative.
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
Edward Camacho Mina 1061 MD4 WINDSOR UNIVERSITY HODGKIN LYMPHOMA.
The acute Leukemias are clonal hematopoietic malignant disease that arise from the malignant T r a n s f o r m a t i o n of an early Hematopoietic stem.
Jan Żeromski Pathology 2010/2011.  Malignant proliferation of white cells of the hematopoietic system with infestation of blood and usually bone marrow.
C HRONIC LEUKEMIAS. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
Myeloproliferative Disorders (MPDs)
Cancer of the blood: Leukemia
Leukaemias and lymphomas. Etiology, pathogenesis. Diagnostics
4th Year Medical Student KAU
Hematology and Hematologic Malignancies
Chronic leukemia 1. Chronic Lymphocytic leukemia (CLL) * Definition: Chronic neoplastic disorder characterized by accumulation of small mature-looking.
Lymphoma Rob Jones. Aim and learning outcomes Aim ◦ To revise the key points of lymphoma Learning outcomes ◦ Revise the basics of haemopoiesis ◦ Understand.
CHRONIC LEUKEMIA Dr. Hayam Hebah Associate professor of Internal Medicine AL Maarefa College.
Heterogeneous group of hematopoietic neoplasms Uncontrolled proliferation and decreased apoptotic activity with variable degrees of differentiation Composed.
8/12/20091 Leukemia. 2 Leukemia A group of malignant disorders affecting the blood and blood-forming tissues of A group of malignant disorders affecting.
Leukaemias. Leukaemias: Malignant Disease of WBC Forming tissue or other hemopoietic elements: Lymphoblastic (ALL) Lymphoblastic (ALL)Acute Myeloid (AML)
..  Neoplastic proliferation of small mature appearing  lymphocytes and account 25% of leukemia  It is rare before 40 years of age, the median age.
MLAB 1415: Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
White blood cells and their disorders Dr K Hampton Haematologist Royal Hallamshire Hospital.
Acute Leukemia Kristine Krafts, M.D..
By: Ashlynn Hill. Patrice Thompson  3 year who is battling leukemia.  The doctors suggest a bone marrow transplants for a long term survival.  Neither.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 28 Disorders of White Blood Cells and Lymphoid Tissues.
LEUKEMIA Dr. Omar Alshaer. Acute Leukemia.
Acute lymphoblastic leukemia in children
CHAPTER 7 DISORDERS OF BLOOD CELLS & VESSELS. HEMATOPOIESIS Generation of blood cells Lymphoid progenitor cells = lymphocytes (WBCs) Myeloid progenitor.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives chronic myeloid leukaemia (CML) Haematopoietic malignancies Polycythemia vera (PV) Idiopathic myelofibrosis.
Lymphoma David Lee MD, FRCPC.
Acute Leukemia Kristine Krafts, M.D..
Blood Biochemistry BCH 577
Malignancies of hematopoietic cells. Leukemia
Acute myeloid leukemia
Leukemia DR Ahmed Gamal Consultant Adult hematology and SCT , KKUH
LEUKEMIAS H.A. MWAKYOMA, MD.
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
Lymphoproliferative disorders
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
CHRONIC MYELOID LEUKEMIA (CML)
Associate professor of Internal Medicine
Case Study ….
Chronic Leukemia Kristine Krafts, M.D..
Acute leukemia.
Acute Leukemia Dr. Noha Noufal.
Neoplastic disorder.
Chronic Leukemia Dr. Noha Noufal.
LYMPHOPROLIFERATIVE DISORDERS
CHRONIC LEUKEMIA BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST
MYELOID LEUKEMIAS Dr. B.V.Vydehi M.D PROFESSOR OF PATHOLOGY
Presentation transcript:

DISEASES OF WHITE BLOOD CELLS DISEASES OF WHITE BLOOD CELLS Premed 3 Premed 3 Dr Roopa Dr Roopa

What Is Leukemia? Cancer of the white blood cells Cancer of the white blood cells Acute or Chronic Acute or Chronic Affects ability to produce normal blood cells Affects ability to produce normal blood cells Bone marrow makes abnormally large number of immature white blood cells called blasts Bone marrow makes abnormally large number of immature white blood cells called blasts

History Means “white blood” in Greek Means “white blood” in Greek Discovered by Dr. Alfred Velpeau in France, 1827 Discovered by Dr. Alfred Velpeau in France, 1827 Named by pathologist Rudolf Virchow in Germany, 1845 Named by pathologist Rudolf Virchow in Germany, 1845

Leukemias ↑ leukocytes ↑ leukocytes Acute leukemias 1. Acute Lymphoblastic Leukemia (ALL) 2. Acute Myelogenous Leukemia (AML) Chronic leukemias 1.Chronic Lymphoblastic Leukemia (CLL) 2. Chronic Myelogenous Leukemia (CML)

Treatment may involve some combination of chemotherapy, radiation therapy, targeted therapy, and bone marrow transplant, in addition to supportive care and palliative care as needed. chemotherapyradiation therapytargeted therapybone marrow transplant supportive care palliative care

The success of treatment depends on the type of leukemia and the age of the person.

Acute Leukemias Blast predominate Blast predominate Child or elder Child or elder Short & drastic course Short & drastic course ALL – Lymphoblasts (pre-B or pre-T) ALL – Lymphoblasts (pre-B or pre-T) AML – Myeloblasts AML – Myeloblasts

Chronic Leukemias More mature cells More mature cells Middle age Middle age Longer & less devastating course Longer & less devastating course CLL – Lymphocytes CLL – Lymphocytes CML – Myeloid stem cells CML – Myeloid stem cells

Acute Leukemias accumulation of blasts in the marrow accumulation of blasts in the marrow

Acute Lymphoblastic Leukemia (ALL) Children Children Lymphoblasts (pre-B or pre-T) Lymphoblasts (pre-B or pre-T) Neoplastic transformation of the Neoplastic transformation of the lymphoid stem cells Progressive accumulation of Lymphoblasts in the bone marrow Progressive accumulation of Lymphoblasts in the bone marrow Suppression of normal hemopoiesis Suppression of normal hemopoiesis

ALL

Primarily a disease of childrenand old age Primarily a disease of childrenand old age B-cell subtype(80%) B-cell subtype(80%) T-cell subtype(20%) T-cell subtype(20%)

ALL - Pathogenesis Etiology unknownEtiology unknown Genetic predisposition (some)Genetic predisposition (some) Down syndrome Translocations (worse prognosis)Translocations (worse prognosis) t(4;11)t(12;21)t(9;22)

Signs &Symptoms Anemia Anemia Infection Infection Bleeding Bleeding Bone pain Bone pain Arthritis Arthritis Splenomegaly Splenomegaly Lymphadenopathy Lymphadenopathy CNS involvement CNS involvement

ALL Prognosis: Age 3-7, pre-B, L1 :Age 3-7, pre-B, L1 : > 90% - CR( 2/3 - cure ) Adults, mature B and T-ALL:Adults, mature B and T-ALL: Less favorable Therapy: Chemotherapy ( w/CNS prophylaxis ), supportive care, BMT

ACUTE MYELOGENOUS LEUKEMIA ( AML ) - Adults - Myeloblasts - monoblasts, eosinoblasts, megakarioblasts, proerythroblasts, basophiloblasts - Auer rods in the cytoplasm of the cells - Very rapidly progressive malignancy

AML

Auer rods in AML

AML - Pathogenesis Environmental factors: High-dose radiation exposure Myelotoxic agents (benzene, alkylating agents) Genetic abnormalities: Down syndrome, Immunodeficiency diseases

Differentiation from ALL may be made by microscopy – presence of Auer Rods. Differentiation from ALL may be made by microscopy – presence of Auer Rods. Clinical features based on Marrow failure –anemia, bleeding, DIC, infection… Marrow failure –anemia, bleeding, DIC, infection… Leukemic infiltration – bone pain, CNS signs, hepatosplenomegaly, lymphadenopathy… Leukemic infiltration – bone pain, CNS signs, hepatosplenomegaly, lymphadenopathy… Constitutional upset -- malaise, fever, weakness, polyarthritis. Constitutional upset -- malaise, fever, weakness, polyarthritis.

Course: Rapidly fatal if untreated (< 2 mo )Rapidly fatal if untreated (< 2 mo ) Median survival - 3 years after chem..Median survival - 3 years after chem.. Adverse prognostic factors:Adverse prognostic factors: Age > 60 t(9;21), Previous chemotherapy Leukocytosis > 100,000 /ul Therapy:Chemotherapy, supportive, BMT

***Remember this*** For Acute leukemias acute leukemias = too many blasts in the marrow acute leukemias = too many blasts in the marrow 2 broad categories: AML vs. ALL 2 broad categories: AML vs. ALL a hematologic urgency a hematologic urgency prognosis is poor in adults; but good in kids with ALL. prognosis is poor in adults; but good in kids with ALL.

CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) A monoclonal lymphoproliferative disorder characterized by lymphocytosis(>4000/cu.mm), lymphadenopathy and splenomegaly B - CLL > 95% T - CLL

CLL Most common adult leukemia inMost common adult leukemia in Western society (30% of all leukemias) Monoclonal proliferation of the small lymphocytes…Monoclonal proliferation of the small lymphocytes… Age > 40M:F / 2:1Age > 40M:F / 2:1

CLL PB and BM

CLL - Pathology Blood: LymphocytosisLymphocytosis ( > 10,000 u/L - diagnostic ) (+) Coombs test (20%)(+) Coombs test (20%) Hypogammaglobulinemia (50-70%)Hypogammaglobulinemia (50-70%) Anemia, thrombocytopenia, neutropeniaAnemia, thrombocytopenia, neutropenia Bone marrow: nodular / interstitial infiltratesnodular / interstitial infiltrates diffuse - obliteration of normal hemopoiesisdiffuse - obliteration of normal hemopoiesis Lymphadenopathy, Hepatosplenomegaly (50-60%)

CLL - Clinical course Initially: asymptomatic Advanced disease: bacterial infections, hemorrhagebacterial infections, hemorrhage Prognostic factors: extent of tumor burdenextent of tumor burden pattern of marrow infiltrationpattern of marrow infiltration chromosomal abnormalitieschromosomal abnormalities Median survival:~ 6 years

Smudge cells - CLL

CLL One more peripheral blood findings in CLL is Presence of Smudge cells One more peripheral blood findings in CLL is Presence of Smudge cells ( parachute cells). ( parachute cells). Along with increased number of normal appearing lymphocytes. Along with increased number of normal appearing lymphocytes.

8/12/ Chronic Myelogenous Leukemia (CML) Excessive development of mature neoplastic granulocytes in the bone marrow Excessive development of mature neoplastic granulocytes in the bone marrow Move into the peripheral blood in massive numbers Move into the peripheral blood in massive numbers Ultimately infiltrate the liver and spleen Ultimately infiltrate the liver and spleen

8/12/ Chronic Myelogenous Leukemia Philadelphia chromosome Philadelphia chromosome 9 and 22 translocation almost specific to CML 9 and 22 translocation almost specific to CML Produces BCR/c-abl fusion oncogene Produces BCR/c-abl fusion oncogene The chromosome abnormality that causes chronic myeloid leukemia (CML) (9 &22) The chromosome abnormality that causes chronic myeloid leukemia (CML) (9 &22)chromosome chronicmyeloidleukemiachromosome chronicmyeloidleukemia Genetic marker Genetic marker Chronic, stable phase followed by acute, aggressive (blastic) phase Chronic, stable phase followed by acute, aggressive (blastic) phase

i.e – mainly uncontrolled proliferation of myeloid cells. i.e – mainly uncontrolled proliferation of myeloid cells. Males more than females Males more than females Splenomegaly – sometimes massive.. Splenomegaly – sometimes massive..

**Philadelphia chromosome** Hybrid chromosome with translocation between the long arm of chr. 9 and long arm of chr t(9:22). Hybrid chromosome with translocation between the long arm of chr. 9 and long arm of chr t(9:22). May be present in granulocyte, RBC or platelet precursors in more than 95% of CML.. May be present in granulocyte, RBC or platelet precursors in more than 95% of CML..

CML - Pathology Bone marrow: Hypercellular / predominant granulocytic hyperplasia Hypercellular / predominant granulocytic hyperplasia Increased megakaryocytes (small forms) Increased megakaryocytes (small forms) Normal to decreased erythroid precursors Normal to decreased erythroid precursors Peripheral blood: Granulocytosis (>25,000/cmm), with immature cells, Granulocytosis (>25,000/cmm), with immature cells, Basophilia, eosinophilia, Basophilia, eosinophilia, Extramedullary hemopoiesis: Spleen, liver, lymph nodes

CML - Clinical Features % of all leukemias; age Symptoms: - non-specific - related to hypermetabolism (high cell turnover) - related to splenomegaly Course: - chronic phase (mean survival, 3-4y) - accelerated phase - blast crisis / myeloid or lymphoid (survival, < 1y) Therapy: chemotherapy; BMT

Hodgkin’s lymphoma a lymphoid neoplastic disorder of B cell origin a lymphoid neoplastic disorder of B cell origin A disease marked by chronic enlargement of the lymph nodes, often local at the onset and later generalized. A disease marked by chronic enlargement of the lymph nodes, often local at the onset and later generalized. characterized by the presence of Reed- Sternberg cells (or variants of RS cells) in the affected tissues characterized by the presence of Reed- Sternberg cells (or variants of RS cells) in the affected tissues Enlargement of the spleen and often of the liver is also present. Enlargement of the spleen and often of the liver is also present.

Reed-Sternberg cells Considered to be a malignant neoplasm of lymphoid cells of uncertain origin. Considered to be a malignant neoplasm of lymphoid cells of uncertain origin. Owl – Eye appearance Owl – Eye appearance These cells have mirror-image nuclei. These cells have mirror-image nuclei. Young adults and elderly Young adults and elderly

Signs & Symptoms Enlarged painless nodes – mostly neck & axilla Enlarged painless nodes – mostly neck & axilla Fever, wt.loss, pruritis & night sweats. Fever, wt.loss, pruritis & night sweats. Pel – Ebstein Fever – fever alternating with long periods (15-28days). Pel – Ebstein Fever – fever alternating with long periods (15-28days). Anemia Anemia Cachexia Cachexia Hepatosplenomegaly Hepatosplenomegaly

Hodgkin’s disease: Summary a lymphoid neoplasm of B cell origin a lymphoid neoplasm of B cell origin characterized histologically by Reed Sternberg cells (or variants) characterized histologically by Reed Sternberg cells (or variants) commonly presents with lymphadenopathy or mediastinal mass in young adults commonly presents with lymphadenopathy or mediastinal mass in young adults treatment modality depends on stage treatment modality depends on stage curable in most curable in most

Non Hodgkin's Lymphoma These include all lymphomas without Reed-Sternberg cells. These include all lymphomas without Reed-Sternberg cells. Most are B-cell proliferations Most are B-cell proliferations Extra nodal involvement is there.. Extra nodal involvement is there..

Signs & Symptoms Often symptomless Often symptomless Lymphadenopathy, wt.loss.. Lymphadenopathy, wt.loss.. Extra nodal spread – skin, bone, gut, CNS, lung.. Extra nodal spread – skin, bone, gut, CNS, lung.. Pancytopenia may be there Pancytopenia may be there Infections are very common. Infections are very common. Fatigue, unexplained fever, sweats Fatigue, unexplained fever, sweats Enlarged Tonsils and adenoids Enlarged Tonsils and adenoids

FOLLICULAR LYMPHOMA Follicular lymphoma’s – most common in US Follicular lymphoma’s – most common in US Derived from B lymphocytes Derived from B lymphocytes t (14:18) t (14:18) Affects middle age Affects middle age Not very aggressive – mean survival 7-10 yrs Not very aggressive – mean survival 7-10 yrs Rarely they may transform in to aggressive type of lymphomas Rarely they may transform in to aggressive type of lymphomas

Burkitt’s Lymphoma A Lymphoblastic lymphoma mainly in African children. A Lymphoblastic lymphoma mainly in African children. Mostly associated with EBV infection. Mostly associated with EBV infection. Involves facial bones ( Jaw), ovaries, and abdominal lymph nodes. Involves facial bones ( Jaw), ovaries, and abdominal lymph nodes. Undifferentiated stem cells with scattered pale macrophages containing nuclear debris. Undifferentiated stem cells with scattered pale macrophages containing nuclear debris. Isolated histiocytes on background of abnormal lymphoblasts (STARRY SKY APPERANCE) Isolated histiocytes on background of abnormal lymphoblasts (STARRY SKY APPERANCE) t (8:14) t (8:14) High incidence in AIDS pt’s High incidence in AIDS pt’s

Burkitts lymphoma